Denosumab and Atypical Femoral Fractures: A Scoping Literature Review

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Ismail Ammar; Bekhet Amira Hassan; Abushouk Abdelrahman Ibrahim; MIRBAHA SAHAR; BARATLOO ALIREZA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: TRAUMA MONTHLY Year:2018 | Volume:23 | Issue:1 Page(s): 0-0

Download Full-Text

View:

174

Download:

Cites:

Information Journal Paper

Title

Denosumab and Atypical Femoral Fractures: A Scoping Literature Review

Author(s)

Keywords

Atypical Femoral Fractures

Denosumab

Osteoporosis

Abstract

Background: Atypical femoral fracture (AFF) is a tensile fracture with unique radiographic and clinical features that differ from ordinary osteoporotic femoral fractures. Denosumab is a novel agent that inhibits osteoclastic activity, reducing bone resorption. Within the past few years, several case reports indicated that patients on Denosumab prescription are at risk of AFF. The purpose of this review was to discuss the current evidence regarding this association and draw recommendations for clinicians about the use of Denosumab in osteoporotic patients, until such evidence is established in future studies. Methods: A computer search of Medline (through PubMed and OVID search) engines was conducted using the following keywords: “ Denosumab” and “ Atypical Femoral Fractures” . Furthermore, we reviewed the reference list of included studies for further citations. Results: We identified 9 case reports, 5 clinical trials, and 1 prospective observational study that have reported data regarding the incidence of AFF in patients on Denosumab prescription. Conclusions: Denosumab is an effective treatment for Osteoporosis; however, there is a growing number of reports regarding its association with AFF. Causality needs verification in future observational and interventional studies; meanwhile, screening for AFF in patients receiving Denosumab and reevaluating the optimal antiresorptive therapy in osteoporotic patients is recommended.

Cites

No record.

References

No record.

Cite

APA: Copy

Ismail, Ammar, Bekhet, Amira Hassan, Abushouk, Abdelrahman Ibrahim, MIRBAHA, SAHAR, & BARATLOO, ALIREZA. (2018). Denosumab and Atypical Femoral Fractures: A Scoping Literature Review. TRAUMA MONTHLY, 23(1), 0-0. SID. https://sid.ir/paper/767657/en

Vancouver: Copy

Ismail Ammar, Bekhet Amira Hassan, Abushouk Abdelrahman Ibrahim, MIRBAHA SAHAR, BARATLOO ALIREZA. Denosumab and Atypical Femoral Fractures: A Scoping Literature Review. TRAUMA MONTHLY[Internet]. 2018;23(1):0-0. Available from: https://sid.ir/paper/767657/en

IEEE: Copy

Ammar Ismail, Amira Hassan Bekhet, Abdelrahman Ibrahim Abushouk, SAHAR MIRBAHA, and ALIREZA BARATLOO, “Denosumab and Atypical Femoral Fractures: A Scoping Literature Review,” TRAUMA MONTHLY, vol. 23, no. 1, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/767657/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops